Pier Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-60,422
Closed -$7.21M 127
2021
Q3
$7.21M Sell
60,422
-1,191
-2% -$131K 0.75% 75
2021
Q2
$6M Sell
61,613
-9,417
-13% -$840K 0.6% 92
2021
Q1
$6.27M Buy
71,030
+4,950
+7% +$460K 0.59% 87
2020
Q4
$6.32M Buy
66,080
+2,301
+4% +$237K 0.67% 84
2020
Q3
$7.24M Sell
63,779
-1,869
-3% -$196K 1.06% 50
2020
Q2
$6.49M Sell
65,648
-27,393
-29% -$2.19M 1.04% 50
2020
Q1
$5.99M Sell
93,041
-32,855
-26% -$2.3M 1.32% 20
2019
Q4
$7.5M Buy
125,896
+16,953
+16% +$1.05M 1.23% 30
2019
Q3
$6.42M Buy
108,943
+3,964
+4% +$253K 1.09% 51
2019
Q2
$6.77M Buy
+104,979
New +$6.78M 1.05% 55
2014
Q3
Sell
-14,254
Closed -$2.32M 157
2014
Q2
$2.32M Sell
14,254
-15,766
-53% -$2.68M 0.33% 101
2014
Q1
$6.63M Sell
30,020
-3,661
-11% -$934K 0.85% 75
2013
Q4
$8.68M Buy
+33,681
New +$7.71M 1.16% 26

Other funds holding TNDM

Pier Capital's TNDM Position: Q4 2021 in Review

Pier Capital sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 60,422 shares — an estimated $7.21M sold.

Pier Capital first reported a position in TNDM in Q4 2013 and held it in 13 quarters. The position peaked at $8.68M in Q4 2013. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

  • Pier Capital reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
  • Pier Capital sold 60,422 Tandem Diabetes Care shares in Q4 2021, an estimated $7.21M.
  • Pier Capital first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 13 quarters.
  • Pier Capital's Tandem Diabetes Care position peaked at $8.68M in Q4 2013.
  • 388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Pier Capital's 13F filing for Q4 2021, filed 10 Feb 2022.